Growth Metrics

Kestra Medical Technologies (KMTS) Debt to Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) reported Debt to Equity of $0.15 for Q1 2026, up 186.5% year-over-year from $0.05 in Q1 2025, and down 42.5% on a QoQ basis from $0.26 in Q4 2025.

Kestra Medical Technologies (KMTS) has 3 years of Debt to Equity data on file, last reported at $0.15 in Q1 2026.

  • Quarterly Debt to Equity rose 186.5% year-over-year to $0.15 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $0.15 (up 186.5% YoY) and the FY2025 annual result came in at $0.2, up 198.49% from the prior year.
  • Debt to Equity retreated to $0.15 in Q1 2026 per KMTS's latest filing, from $0.26 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.26 in Q4 2025 and bottomed at -$0.2 in Q2 2024.
  • The 3-year median for Debt to Equity is $0.17 (2025), against an average of $0.08.
  • The widest annual swing landed in 2025, when Debt to Equity soared 198.49%; it then surged 186.5% in 2026.
  • Tracing KMTS's Debt to Equity over 3 years: stood at -$0.2 in 2024, then surged by 225.62% to $0.26 in 2025, then sank by 42.5% to $0.15 in 2026.
  • Per Business Quant, the three latest KMTS Debt to Equity figures stand at $0.15 (Q1 2026), $0.26 (Q4 2025), and $0.23 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.72
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.04
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.07
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 1.02
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.30
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 1.57
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.45
10 Kestra Medical Technologies 1.13 Bn 840.05 Mn 12.91 Mn 0.15

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 0.15
Oct 31, 2025 0.26
Jul 31, 2025 0.23
Apr 30, 2025 0.20
Jan 31, 2025 -0.17
Apr 30, 2024 -0.20